Change of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme

Table 1 Description of included individuals according to entry period

	Period 1		Period 2		Period 3		P*
Group–n (%)
Men	6,643	(27.6)	2,640	(30.9)	2,582	(31.0)	<0.001
Women < 40 years old	13,851	(57.5)	4,867	(57.0)	4,681	(56.2)
Women ≥40 years old	3,588	(14.9)	1,028	(12.1)	1,071	(12.8)
CD4 count (cells/μL) - median [IQR]
In men	180 [71–341]		183 [74–335]		229 [100–386]		<0.001
In women <40 years old	307 [164–481]		288 [158–458]		349 [213–520]		<0.001
In women ≥40 years old	258 [135–432]		242 [119–419]		333 [161–522]		<0.001
Age (years)-median [IQR]
In men	36.5 [30.4-44.5]		34.8 [28.7-43.0]		34.5 [28.3-42.0]		<0.001
In women <40 years old	27.5 [23.4-32.6]		26.5 [22.5-31.2]		26.7 [22.4-31.6]		<0.001
In women ≥40 years old	46.8 [43.2-51.9]		46.9 [42.9-53.0]		48.0 [43.7-53.4]		<0.001

IQR: Inter-Quartile Interval
Period 1: January 1, 2007–March 31, 2010; Period 2: April 1, 2010–July 31, 2011; Period 3: August 1, 2011–September 15, 2012
* p.value with Chi2 tests (for group) or Anova tests (for CD4 cells count and Age)
HIV Hlabisa programme, KwaZulu-Natal, South Africa. 2007–2012

ISSN: 1471-2334